Elanco Animal Health Slides as Analyst Downgrade Pressures Shares

Elanco Animal Health (ELAN) is down 3.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely catalyst is an analyst downgrade that hit the stock before the open and reset expectations for the animal health group. The move appears tied less to a company-specific operational setback today and more to fresh concerns that pricing power across the sector may weaken, which can matter for a company expected to rely heavily on execution and margin improvement.

Details:

Jefferies downgraded ELAN to Hold from Buy and cut its price target to $24 from $31, a notable reset in expected upside.

The downgrade was tied to rising concern about pricing risk in animal health, with the view that sector pricing may become harder to sustain.

Elanco has recently emphasized volume growth, market-share gains, and momentum from newer products, so a market shift toward lower pricing confidence could weigh on how investors value that progress.

Recent company materials had pointed to improved 2026 execution and stronger innovation momentum, which may have made the negative rating change stand out more sharply against an otherwise improving narrative.

Sources:

Elanco Investor Relations, Investing.com, MarketScreener

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$ELAN Insider Trading Activity

$ELAN insiders have traded $ELAN stock on the open market 7 times in the past 6 months. Of those trades, 6 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $ELAN stock by insiders over the last 6 months:

LAWRENCE ERIK KURZIUS purchased 40,000 shares for an estimated $935,920
PAUL HERENDEEN purchased 10,000 shares for an estimated $236,850
MICHAEL J HARRINGTON purchased 5,000 shares for an estimated $109,100
TIMOTHY J BETTINGTON (SEE REMARKS) sold 4,350 shares for an estimated $100,050
RAJEEV A. MODI (SEE REMARKS) purchased 4,911 shares for an estimated $99,938
JEFFREY N SIMMONS (PRESIDENT, CEO AND DIRECTOR) purchased 4,971 shares for an estimated $99,842
ROBERT M VANHIMBERGEN (EVP and CFO) purchased 4,200 shares for an estimated $96,925

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive ELAN Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$ELAN Hedge Fund Activity

We have seen 245 institutional investors add shares of $ELAN stock to their portfolio, and 263 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 12,014,054 shares (+71.8%) to their portfolio in Q2 2026, for an estimated $295,665,868
FMR LLC added 6,023,453 shares (+11.8%) to their portfolio in Q2 2026, for an estimated $148,237,178
BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 3,581,778 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $88,147,556
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 3,553,213 shares (+inf%) to their portfolio in Q2 2026, for an estimated $87,444,571
MARSHALL WACE, LLP added 3,049,938 shares (+220.6%) to their portfolio in Q2 2026, for an estimated $75,058,974
INVESCO LTD. removed 2,834,846 shares (-34.8%) from their portfolio in Q2 2026, for an estimated $69,765,560
BLACK CREEK INVESTMENT MANAGEMENT INC. added 2,552,571 shares (+24.3%) to their portfolio in Q2 2026, for an estimated $62,818,772

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$ELAN Analyst Ratings

Wall Street analysts have issued reports on $ELAN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

JP Morgan issued a "Overweight" rating on 05/07/2026

To track analyst ratings and price targets for $ELAN, check out Quiver Quantitative's $ELAN forecast page.

$ELAN Price Targets

Multiple analysts have issued price targets for $ELAN recently. We have seen 3 analysts offer price targets for $ELAN in the last 6 months, with a median target of $31.0.

Here are some recent targets:

Steve Scala from TD Cowen set a target price of $32.0 on 06/18/2026
Chris Schott from JP Morgan set a target price of $30.0 on 05/07/2026
Daniel Grosslight from Citigroup set a target price of $31.0 on 05/07/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.